157 related articles for article (PubMed ID: 17685214)
1. Management of transitional cell carcinoma of the urinary bladder at Kenyatta National Hospital, Nairobi.
Waihenya CG; Mungai PN
East Afr Med J; 2006 Dec; 83(12):679-83. PubMed ID: 17685214
[TBL] [Abstract][Full Text] [Related]
2. Pattern of transitional cell carcinoma of the urinary bladder as seen at Kenyatta National Hospital, Nairobi.
Waihenya CG; Mungai PN
East Afr Med J; 2004 Mar; 81(3):114-9. PubMed ID: 15293967
[TBL] [Abstract][Full Text] [Related]
3. Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique.
Borgaonkar S; Jain A; Bollina P; McLaren DB; Tulloch D; Kerr GR; Howard GC
Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):141-7. PubMed ID: 12069124
[TBL] [Abstract][Full Text] [Related]
4. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
[TBL] [Abstract][Full Text] [Related]
5. The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy.
Hellenthal NJ; Ramirez ML; Evans CP; Devere White RW
BJU Int; 2010 Feb; 105(4):485-8. PubMed ID: 19849694
[TBL] [Abstract][Full Text] [Related]
6. [Radical cystectomy in the treatment of bladder cancer always in due time?].
May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.
Supit W; Mochtar CA; Sugiono M; Umbas R
Asian Pac J Cancer Prev; 2011; 12(2):549-53. PubMed ID: 21545228
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
10. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
11. The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder.
Chen SS; Chen KK; Lin AT; Chang YH; Wu HH; Hsu TH; Chang LS
Br J Urol; 1996 Aug; 78(2):209-12. PubMed ID: 8813915
[TBL] [Abstract][Full Text] [Related]
12. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.
Supit W; Mochtar CA; Santoso RB; Umbas R
Asian J Surg; 2014 Oct; 37(4):184-9. PubMed ID: 24637186
[TBL] [Abstract][Full Text] [Related]
14. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy in different risk-groups of patients with superficial bladder cancer.
Startsev V; Pouline I
Arch Ital Urol Androl; 2005 Jun; 77(2):93-8. PubMed ID: 16146269
[TBL] [Abstract][Full Text] [Related]
16. Sarcomatoid urothelial carcinoma of the bladder with osseous metaplasia: bone in urinary bladder.
Varshney B; Choudhary GR; Yadav T; Nalwa A
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33906873
[TBL] [Abstract][Full Text] [Related]
17. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR.
Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J
BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557
[TBL] [Abstract][Full Text] [Related]
19. Superficial bladder tumours: recurrence and progression.
Mansoor M; Ali S; Fasihuddin Q; Baloch MU
J Coll Physicians Surg Pak; 2011 Mar; 21(3):157-60. PubMed ID: 21419022
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
